Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndromeCai, Qian-Qian; Wang, Chen; Cao, Xin-Xin; Cai, Hao; Zhou, Dao-Bin; Li, Jian · European Journal of Haematology · 2015

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal functionMeletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; Jeffrey A. Zonder; Carlos M. de Castro; Zvenyslava Masliak; Donna Reece; Marta Olesnyckyj; Zhinuan Yu; Donna M. Weber · 2010

LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemiaGohil, Satyen Harish; Maciocia, Nicola; Patrick, Pip; Roberts, Thomas; Counsell, Nicholas; Smith, Paul; Clifton-Hadley, Laura; Cwynarski, Kate; Pettitt, Andrew; Nathwani, Amit Chunilal · Leukemia & Lymphoma · 2017

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomibMian, Michael; Pescosta, Norbert; Badiali, Stefania; Cappelletto, Paola Cristina; Marcheselli, Luigi; Luminari, Stefano; Patriarca, Francesca; Zambello, Renato; Pascarella, Anna; Tagariello, Giuseppe; Marabese, Alessandra; Mondello, Patrizia; Billio, Atto; Cortelazzo, Sergio · British Journal of Haematology · 2018

Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077Pönisch, Wolfram; Heyn, Simone; Beck, Juliane; Wagner, Ina; Mohren, Martin; Hoffmann, Franz A.; Lange, Thoralf; Schmalfeld, Marion; Zehrfeld, Thomas; Schwarzer, Andreas; Winkelmann, Cornelia; Edelmann, Thomas; Röhrborn, Ramona; Hebenstreit, Karin; Al-Ali, Haifa K.; Jäkel, Nadja; Niederwieser, Dietger · British Journal of Haematology · 2013

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay; Chanan-Khan, Asher · Leukemia & Lymphoma · 2016

Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantationFerreri, Andrés J. M.; Sassone, Marianna; Angelillo, Piera; Zaja, Francesco; Re, Alessandro; Di Rocco, Alice; Spina, Michele; Fabbri, Alberto; Stelitano, Caterina; Frezzato, Maurizio; Volpetti, Stefano; Zambello, Renato; Rusconi, Chiara; De Lorenzo, Daniela; Scarano, Eloise; Arcari, Annalisa; Bertoldero, Giovanni; Nonis, Alessandro; Calimeri, Teresa; Perrone, Salvatore; Cecchetti, Caterina; Tarantino, Vittoria; Steffanoni, Sara; Foppoli, Marco; Ciceri, Fabio; Ponzoni, Maurilio · Hematological Oncology · 2020

Big Data for Cancer ResearchCho, William C. · Clinical Medicine Insights: Oncology · 2015

Trends in Cancer ImmunotherapyMurphy, Joseph F. · Clinical Medicine Insights: Oncology · 2010

CorrigendumClinical Medicine Insights: Oncology · 2018

Cancer-Associated Thrombosis: An OverviewElyamany, ; Alzahrani, ALi Mattar; Bukhary, Emam · Clinical Medicine Insights: Oncology · 2014

Bevacizumab for the Treatment of Recurrent GlioblastomaChamberlain, · Clinical Medicine Insights: Oncology · 2011

Treatment Options in Cushing’s DiseasePsaras, ; Ahmed Rizk, ; Honegger, ; Monika Milian, ; Psaras, · Clinical Medicine Insights: Oncology · 2012

The Challenge of Metastatic Colorectal CancerCidón, Esther Uña · Clinical Medicine Insights: Oncology · 2010

Leiomyosarcoma of the Splenic VeinAguilar, Cristian; Socola, Francisco; Donet, Jean A.; Gallastegui, Nicolas; Hernandez, Gabriel A. · Clinical Medicine Insights: Oncology · 2013